InspireMD(NSPR) - 2025 Q1 - Quarterly Results

Exhibit 99.1 InspireMD Reports First Quarter 2025 Financial Results — Management to host investor conference call today, May 9, at 8:30am ET — Miami, FL — May 9, 2025 – InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced financial and operating results for the first quarter ended March 31, 2025. Business Highlights: Marvin Slosman, CEO of InspireMD, commented: "In the first quarter we contin ...